Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TroVax and metronomic cyclophosphamide in inoperable colorectal cancer
ISRCTN54669986Phase 2Completed
- Sponsor
- Cardiff University
- Start
- Apr 2011
- Modality
- Small Molecules, Oncolytic Viruses → Oncolytic Therapeutics, Vaccines & Immunotherapeutics
01
Overview
Phase 2, randomised, open-label trial of MVA-5T4 and cyclophosphamide in colorectal cancer (CRC) (4 arms), sponsored by Cardiff University. Primary endpoints: Reduction in regulatory T-cell frequency or function, Development or increase in T-cell responses and 1 more. Started Apr 2011; status: completed.
02
Drugs
MVA-5T4cyclophosphamide
03
Conditions
colorectal cancer (CRC)
Beyond the preview
Go deeper on ISRCTN54669986.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN54669986.